Major morbidity after pelvic exenteration: a seven-year experience

Area of Science:

• Oncology
• Surgical Oncology
• Gynecologic Oncology

Background:

• Pelvic exenteration is a complex surgical procedure for advanced pelvic malignancies.
• Recurrent cervical cancer is a primary indication for pelvic exenteration.
• Understanding factors influencing postoperative morbidity is crucial for patient management.

Purpose of the Study:

• To analyze the outcomes of pelvic exenteration at a single institution.
• To identify risk factors associated with major postoperative morbidity.
• To discuss strategies for minimizing complications after pelvic exenteration.

Main Methods:

• Retrospective review of 38 patients undergoing pelvic exenteration over seven years.
• Multivariate logistic regression analysis to identify predictors of morbidity.
• Assessment of operative mortality and postoperative complication rates.

Main Results:

• Operative mortality was 5.3% in 38 patients.
• Major morbidity occurred in 21 patients, with 11 requiring reoperation for gastrointestinal or urinary tract complications.
• Significant correlations were found between pelvic radiation, pelvic floor type, pelvic drain type, blood loss, race, and postoperative morbidity.

Conclusions:

• Pelvic exenteration for recurrent cervical cancer is associated with significant morbidity.
• Preoperative factors including radiation dose and patient race, alongside intraoperative factors like blood loss, influence postoperative outcomes.
• Developing strategies to mitigate these identified risk factors is essential for improving patient recovery and reducing reoperation rates.